Bin Yu

Also affiliated with Zhengzhou University, University of Chicago, Key Laboratory of Guangdong Province, First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Shaoxing City Women and Children Hospital, Sarepta Therapeutics (United States)

Biochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor”.

Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor

Acta Pharmaceutica Sinica B(2022)10.1016/j.apsb.2022.03.023

N/A

0DataRank · unranked

35 citations

Qiu‐Xu Teng, Shuai Wang, Zi‐Ning Lei, Huihui Hu, Huifang Lv +9 more